Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 8 to 10 amino acid residues in defined sequence
Patent
1997-06-23
2000-02-15
Cunningham, Thomas M.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
8 to 10 amino acid residues in defined sequence
530300, 514 15, 4241851, 4242771, C07K 412, C07K 704
Patent
active
06025470&
ABSTRACT:
Nonapeptides and decapeptides which bind to HLA molecules and provoke proliferation of cytolytic T cells are disclosed. The decapeptides terminate in Valine, and are restricted in their first three amino acid positions. Other useful nonapeptides are also disclosed.
REFERENCES:
patent: 5487974 (1996-01-01), Boon-Falleur et al.
patent: 5554506 (1996-09-01), van der Bruggen
patent: 5554724 (1996-09-01), Melief et al.
Rammenssee et al., "MHC Ligands and Peptide Motifs: first listing", Immunogenics 41: 178-228 (1995).
Loftus et al., Identification of Epitope Mimics Recognized by CIL Reactive to the Melanoma/Melanocyte-derived Peptide MART-1 (27-35), J. Exp. Med. 184:647-657 (1996).
Wolfel et al., "Two tyrosinase nonapeptides recongnized on HLA-A2 melanomas by autologous cytolytic T lymphocytes", Eur. J. Immunol. 24: 759-864 (1994).
Wolfel et al., "Analysis of Antigens Recognized on Human-Melanoma Cells by A2 Restricted Cytolytic T Lymphocytes", Int. J. Cancer 55: 237-244 (1993).
van der Bruggen et al., "a peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recongize tumor cells expressming MAGE-3", Eur. J. Immunol. 24: 3038-A2 (1994).
Slinguff et al., "Recognition of Human Melanoma Cells by HLA-A2.1 Restricted Cytolytic T Lymphocytes Is Mediated by At Least Six Shared Peptide Epitopes", J. Immunol. 150(7):2955-2963 (1993).
Ruppert et al., "Prominent Role of Secondary Anchor Residues In Peptide Binding to HLA-A2.1 Molecules", Cell 74: 929-937 (1993).
Hunt et al., "Characterization of Peptides Bound To The Class-1 MHC Molecules HLA-A2.1 By Mass Spectometry", Science 255: 1261-1263 (1992).
Falk et al., "Allele Specific Motifs Revealed by Sequencing of Self Peptides Eluted from MHC Molecules", Nature 351: 290-296 (1991).
Coulie et al., "A New Gene Coding For A Differentiation Antigen Recognized by Autologous Cytolytic T Lymphocytes on HLA-A2 Melanomas", J. Exp. Med. 180: 35-42 (1994).
Anichini et al., "Cytolytic T Cells Directed To Tumor Antigens Not Expressed on Normal Melanocytes Dominate HLA-A2.1 Restricted Immune Repertoire to Melanoma", J. Immunol. 156: 208-217 (1996).
Pancor et al. J. Immunology 149: 3580, 1992.
Ochoa-Garay et al. Mol. Immunol. 34: 273, 1997.
Cerottini Jean-Charles
Romero Pedro
Valmori Danila
Cunningham Thomas M.
Lubet Martha
Ludwig Institute for Cancer Research
LandOfFree
Isolated nona- and decapeptides which bind to HLA molecules, and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated nona- and decapeptides which bind to HLA molecules, and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated nona- and decapeptides which bind to HLA molecules, and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1906954